Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.007 USD | -3.45% | -12.50% | -68.18% |
02-22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-68.18% | 380K | |
+49.97% | 54.63B | |
-4.81% | 39.92B | |
+37.66% | 38.82B | |
+15.52% | 26.86B | |
-12.56% | 26.22B | |
-21.82% | 18.78B | |
+26.01% | 12.21B | |
+2.40% | 12.16B | |
+26.84% | 11.94B |
- Stock Market
- Equities
- BXRX.Q Stock
- News Baudax Bio, Inc.
- Baudax Bio Receives Notice of Patent Allowance Covering Anjeso for Treatment of Moderate to Severe Pain